Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

Excited to share my professional biography, highlighting my journey in the medical device industry, my expertise in quality systems and regulatory compliance, and my passion for driving innovation in healthcare technology. With over a decade of experience, I continue to focus on advancing medical devices through strategic quality initiatives and global regulatory alignment.

I’m excited to share my executive biography, highlighting my experience in R&D, regulatory strategy, and product innovation within the medical device industry. As I transition into board and advisory roles, I look forward to leveraging my expertise to help med-tech companies scale, innovate, and navigate regulatory landscapes.